CMO at Reinventing Health
Following on from her successful panel at Health Tech Integrates earlier this year, Sheuli Porkess gives us her insights to what she sees are the obvious links between using AI in medical device development and public and patient involvement in research.
Patients are taking an increasingly proactive role in the development of new treatments. With an increase in patient and public involvement across research, trials and government initiatives, how are we ensuring we design treatments for the people who need them? And how can we navigate the newly revised transparency rules for the Clinical Trials Information System to avoid intellectual property challenges whilst better supporting patients?
